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Abstract
Background: Involvement of inflammation in pulmonary hypertension (PH) has previously been demonstrated and
recently, immune-modulating dendritic cells (DCs) infiltrating arterial lesions in patients suffering from idiopathic
pulmonary arterial hypertension (IPAH) and in experimental monocrotaline-induced PH have been reported.
Occurrence of perivascular inflammatory cells could be linked to local increase of oxidative stress (OS), as it has
been shown for systemic atherosclerosis. The impact of OS on vascular remodeling in PH is still to be determined.
We hypothesized, that augmented blood-flow could increase OS and might thereby contribute to DC/
inflammatory cell-recruitment and smooth-muscle-cell-proliferation.
Methods: We applied a monocrotaline-induced PH-model and combined it with permanent flow-challenge. Thirty
Sprague-Dawley rats were assigned to following groups: control, monocrotaline-exposure (MCT), monocrotaline-
exposure/pneumonectomy (MCT/PE).
Results: Hemodynamic exploration demonstrated most severe effects in MCT/PE, corresponding in histology to
exuberant medial and adventitial remodeling of pulmonary muscular arteries, and intimal remodeling of smaller
arterioles; lung-tissue PCR evidenced increased expression of DCs-specific fascin, CD68, proinflammatory cytokines
(IL-6, RANTES, fractalkine) in MCT/PE and to a lesser extent in MCT. Major OS enzyme NOX-4 was maximal in MCT/
PE. Antioxidative stress enzymes Mn-SOD and glutathion-peroxidase-1 were significantly elevated, while HO-1
showed maximal expression in MCT with significant decrease in MCT/PE. Catalase was decreased in MCT and MCT/
PE. Expression of NOX-4, but also of MN-SOD in MCT/PE was mainly attributed to a highly increased number of
interstitial and perivascular CXCR4/SDF1 pathway-recruited mast-cells. Stress markers malonedialdehyde and
nitrotyrosine were produced in endothelial cells, medial smooth muscle and perivascular leucocytes of
hypertensive vasculature. Immunolabeling for OX62, CD68 and actin revealed adventitial and medial DC- and
monocyte-infiltration; in MCT/PE, medial smooth muscle cells were admixed with CD68
+/vimentin
+ cells.
Conclusion: Our experimental findings support a new concept of immunologic responses to increased OS in MCT/
PE-induced PAH, possibly linking recruitment of dendritic cells and OS-producing mast-cells to characteristic
vasculopathy.
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Pulmonary arterial hypertension (PAH) is a fatal condi-
tion that may be without obvious cause or complicating
a limited spectrum of conditions [1]. The previous
determination of responsible gene mutations, concern-
ing bone morphogenetic protein receptor II (BMPRII)
[2], activin receptor-like kinase-1 (ALK-1) [3] and recent
discovery of dysregulated genes encoding for hypoxia
inducible factor 3-alpha (HIF-3 alpha), mitochondrial
cytochrome-c oxidase, and superoxide dismutase-2 in
human and experimental PAH [4] provide a new under-
standing of genetic predisposition to PAH. However,
additional biologic abnormalities and histologic features,
such as inflammation, appear to link different forms of
PAH. Indeed, PAH is a common complication of sys-
temic inflammatory conditions, including scleroderma
or systemic lupus erythematosus, and pulmonary arterial
lesions in the lungs of patients suffering from connective
tissue diseases with isolated PAH are often similar to
those found in lungs displaying idiopathic PAH (IPAH)
[5]. Inflammatory cell infiltrates in the range of affected
pulmonary arteries, including macrophages and lympho-
cytes, have been reported in IPAH and PAH associated
with other conditions [5-7]. In addition our group has
previously provided evidence for the recruitment of
monocyte-derived immune-modulating cells, so called
dendritic cells, into pulmonary arterial lesions of both
human PAH and monocrotaline-induced pulmonary
hypertension in rats [8]. Of note, increased plasma con-
centrations of proinflammatory cytokines IL-1 and IL-6
and elevated expression of chemokines RANTES and
fractalkine in endothelial cells of affected pulmonary
arteries have been demonstrated in PAH [9-11]. The
relation of immune responses and inflammatory ele-
ments to the mediation of mitogenic activity through
growth factors initiating endothelial- and smooth-mus-
cle proliferation is of particular interest in the setting of
PAH. We have previously shown that fractalkine, a che-
mokine expressed in endothelial cells of altered pulmon-
ary arteries in patients displaying PAH, not only exerts
chemoattraction on T-lymphocytes and thereby contri-
butes to perivascular inflammation, but additionally
induces smooth muscle cell proliferation [9,8]. Moreover
we have recently reported increased expression of
PDGF-B and -A in the arterial wall of PAH-lungs
(smooth-muscle cells and endothelial cells) and presence
of its receptors PDGFR-beta and -alpha on medial
smooth muscle cells, suggesting a crosstalk between the
intimal and the medial arterial layer, leading to con-
certed vascular compartment reactions and finally to
occlusive remodeling [12].
Oxidative stress (OS) is accepted as a pivotal player in
the pathophysiology of vascular diseases and has been
identified as an important trigger of inflammatory
processes within the vascular wall, especially in the set-
ting of systemic arterial disease [13]. Enhanced superox-
ide (·O2
-) production increases nitric oxide (NO)
inactivation, which constitutes the main vascular vasodi-
lator. Dismutation of superoxide anions and reaction of
NO with ·O2
- leads to an accumulation of hydrogen
peroxide and peroxynitrites, which will cause cell
damage [14,15]. Linkage of reactive oxygen species pro-
duction and expression to chemotactic and mitogenic
factors such as cyclophyllin A has been recently
described for atheromatous lesions and aortic aneurysm
[16]. Satoh and co-workers have shown that this pro-
inflammatory chaperone protein which is secreted from
smooth muscle cells of systemic arteries in response to
ROS is responsible for intimal and medial remodeling,
emphasizing the association of OS, pro-inflammatory
conditions and vascular remodeling. In systemic arteries,
DCs accumulate in regions displaying hemodynamic
stress by turbulent flow conditions and being prone to
hypertensive intimal lesions [17]. A possible link
between DCs and OS in hypertensive diseases is pro-
vided by observations relating increased pulsatile flow
conditions to pathologic generation of ROS in cultured
endothelial cells [18]. Furthermore, Zhu and coworkers
have recently presented experimental data suggesting
that homocysteine-stimulated endothelial cells strikingly
increase ROS generation together with an augmented
DC adhesion and transmigration, while NO release is
markedly decreased [19]. Vice versa, pretreatment with
antioxidant before homocysteine-stimulation markedly
attenuated the induction of DC adhesion and transmi-
gration, dependent on the intracellular ROS decrease
and endothelial NO increase. Finally, recruitment of
macrophages and lymphocytes to pulmonary arteries in
PAH has recently been related to increase of OS pro-
ducts, such as nitrotyrosine, or 8-hydroxyguanosine [20].
On the basis of our observations on recruited DCs in
PAH, we hypothesized that in an high blood-flow trig-
gered stress model of PH, the increase in ROS could
have impact on cell proliferation in typical vascular
lesions and recruited cells, including DCs.
Methods
Animal model and study design
Twelve week-old male, 350- to 400 g, pathogen-free
Sprague-Dawley rats were studied. Rats were randomly
assigned to one of three groups. The control group (C)
(n = 10 at study day 40) was created by a single subcu-
taneous injection of saline on study-day 0. Group MCT
received a single subcutaneous monocrotaline-treatment
on day 0 (n = 10 at study day 40). Group MCT/PE
received a single subcutaneous monocrotaline-treatment
on day 0 and subsequently underwent left pneumonect-
omy on day 7 (n = 10 at study day 40: due to increased
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animals were submitted to pneumonectomy in order to
reach a final group number of 10).
Operative procedures
Monocrotaline (Sigma Aldrich
®)w a sd i s s o l v e di n1N
HCL and pH was adjusted to 7.40 with 1 N NaOH. A
dose of 60 mg/kg was administered to 20 animals on
day 0, by subcutaneous injection into the cervical region.
One week after monocrotaline injection, left pneumo-
nectomy was performed on 10 individuals. Rats were
anesthesized by intraperitoneal injection of ketamine (35
mg/kg), xylasine (4 mg/kg) and acepromazine (0.5 mg/
kg). Rats were then surgically tracheotomized under
aseptic conditions and intubation was performed with a
Cathlon
® 16G by ventilating 2 ml of ambient air, at a
frequency of 60/minute, with PEEP at 1.0 cm H2O.
After shaving the operation site and placing rats in a
half-supine position, thoracotomy and left pneumonect-
omy were performed with aseptic technique. Eventually,
thoracotomy was closed by ligature of muscular and
dermal layers, after positioning of a trans-thoracic drain-
tube. The latter was withdrawn after creation of a nega-
tive intrapleural pressure of -20 mmHg. Finally, rats
were extubated and tracheotomy was closed. All animals
received appropriate care in accordance with the “Prin-
ciples of Laboratory Animal Care” formulated by the
National Society for Medical Research and the Guide
for the Care of Laboratory Animals prepared by the
National Academy of Science and published by the
National Institutes of Health (NIH 86-23, revised 1985).
The study was approved by the administrative panel on
animal care from Centre de Chirurgie Expérimentale
M a r i eL a n n e l o n g u e ,L eP l e s s is-Robinson, and was con-
ducted according to South Paris University regulations.
Hemodynamic studies
On day 40, after final weighing, right ventricular pres-
sure, systolic, diastolic and mean pulmonary arterial
pressures were recorded. Rats were anesthesized as
described above. Right-heart catheterization was per-
formed as previously described
18. An umbilical catheter
(external diameter = 1.2 mm; Tyco
®, Plaisir, France)
was heat-formed to achieve an ideal 90° angle on the
distal extremity (1 cm) and a slightly curved tip. The
catheter was connected to a recording apparatus, con-
sisting of a pressure-head (Ohmeda
®, Trappes, France),
an amplifier (CGR
®, St. Cloud, France) and a recorder
(Sefram
®, St. Etienne, France). The jugular vein was
exposed by blunt dissection. The catheter was inserted
and positioned 2.5 to 3 cm from sting, corresponding to
right intra-auricular position. By rotating the catheter a
right intra-ventricular position was achieved and further
insertion from this point allowed access to the
pulmonary artery, supported by the curved catheter-
form. Throughout this operation, catheter position was
controlled by pressure waveform monitoring of atrium,
ventricle and pulmonary artery.
Tissue preparation
After undergoing hemodynamic measurements, all 30
rats were sacrificed by bleeding through aortal dissec-
tion. Post-mortem explanted lungs were distended by
intra-tracheal infusion of OCT compound (VWR
®),
diluted in phosphate buffered saline (PBS) (1:1), to pre-
serve lung morphology. After quickly freezing in isopen-
tane on dry ice, lungs were stored at -80°C until further
processing.
Explanted hearts of all rats underwent quantitative
morphometry. The right ventricle (RV) was dissected
from left ventricle (LV) and septum (S). Then, RV and
LV+S were weighed and the following ratio was calcu-
lated to estimate right ventricle hypertrophy: [RVweight]/
[(LV+S)weight].
mRNA quantification by real-time reverse transcription
polymerase chain reaction (RT-PCR)
For gene expression quantification by real-time reverse
transcription polymerase chain reaction we used Applied
Biosystems TaqMan Gene Expression Assays with Taq-
Man Universal PCR Master Mix and reactions were run
in an ABI Prism 7000 Sequence Detection System
(Applied Biosystems). Results were analyzed with the
second derivative maximum method to set CT with 18s
as an internal housekeeping gene control. The following
gene expression assays were used: Fascin
(Rn01452400_m1), IL-6 (Rn00561420_m1), CX3CL1
(Rn00593186_m1), RANTES (Rn00579590_m1), CD68
(Rn01495632_m1), HO-1 (Rn00561387_m1), NOX-1
(Rn00586652_m1), NOX-2 (Rn00576710_m1), NOX-3
(Rn01430441_m1), NOX-4 (Rn00585380_m1), Mn-SOD
(Rn00690587_g1), catalase (Rn00560930_m1), Glu-
tathione peroxidase-1 (Rn00577994_g1), and ribosomal
18s (Hs99999901_s1), and tryptase (Rn00570928_m1)
Histochemistry
The right lung from all animals was processed for histo-
morphologic evaluation. Three frozen lung sections (7
μm) from lower, medial and upper lobe of each animal
were stained with erythrosine (RAL
®) and then counter-
stained with Mayer’s hematoxyline (Labonord
®). Evalua-
tion was performed by two experienced pathologists
(PD, FC).
Immunohistochemistry
Immunohistochemical experiments were performed on 7
μm-thick sections of frozen lung tissue. After routine
preparation, rat samples were processed with the
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with the monoclonal anti-CD103 antibody (Pharmin-
gen
®, clone OX-62) diluted in PBS containing 2% nor-
mal rat serum. Rat OX-62 labeling was revealed with
t h ek i tL S A B2f o ru s eo nr a ts p e c i m e n s( D a k o
®).
Macrophages were detected with anti-CD68 (Serotec,
clone ED1), Mast cells with anti-Tryptase (Sigma,
WH0007177M1) Pro-inflammatory cytokines were eval-
uated after staining with antibodies against IL-6
(Abcam, ab6672), RANTES (Torrey Pines, TP211), frac-
talkine (Torrey Pines TP203), and SDF-1 (R&D systems,
MAB350). OS markers were revealed by antibodies
against NOX-4 (Epitomics, 3174-1), MN-SOD (Epi-
tomics, 2299-1), malonedialdehyde (Abcam, ab6463) and
nitrotyrosine (Santa Cruz, (39B6) sc-32757). Staining
was completed after incubation with substrate-chromo-
gen AEC solution (Dako
®). Slides were counterstained
with Mayer’s Hematoxyline (Labonord
®)a n dm o u n t e d
with aqueous medium (Glycergel, Dako
®). Controls
used for these antibodies included omission of the pri-
mary antibody and substitution of the primary antibody
by isotype control.
Immunofluorescent labeling
For double immunofluorescence, anti-rat anti-OX-62-
(Pharmingen), or anti-NOX-4 (Epitomics, 3174-1) anti-
bodies were labeled by Biogenex’s or Dako’s biotinylated
anti-mouse immunoglobulins after overnight incubation
at 4°C and streptavidin, Alexa Fluor 594 or 488 conju-
gate (Molecular Probes) for one hour. Then, the tissues
were incubated overnight either with FITC conjugated,
anti-smooth muscle alpha-actin (Sigma-aldrich clone
1A4), anti-CXCR4 (R&D systems MAB172), rhodamine
conjugated vimentine (Santa Cruz sc-6260), or Alexa
Fluor 488 conjugated anti-rat CD68 (Serotec clone
ED1). The slides were mounted with Vectashield
Mounting Medium with DAPI (Vector Laboratories).
Statistical analysis
All data are given as mean ± SEM. Analysis of variance
(ANOVA) using repeated measures and the Fisher pro-
jected least significant difference (PLSD) post test was
performed on the results. A p value of less than 0.05
was considered significant.
Results
Thirty rats were studied. Ten received saline subcuta-
neous injection, 20 received monocrotaline subcuta-
neous injection (60 mg/kg) and 10 out of these 20
underwent left pneumonectomy. Due to increased peri-
operative mortality of the MCT/PE group, we submitted
a sufficient number of animals to pneumonectomy in
order to reach a group number of 10 on study-day 40.
Hemodynamic data were obtained shortly before
sacrifice on day 40. All morphometry-, RT-PCR-, immu-
nohistochemistry-, and immunofluorescence-experi-
ments were performed after sacrifice (day 40).
Hemodynamics and quantitative morphometry
Monocrotaline-challenged rats (MCT) developed severe
pulmonary hypertension within 40 days. In consequence,
right ventricular systolic pressure (RVSP) and mean pul-
monary artery pressure (mPAP) was increased signifi-
cantly as compared with the control group
(subcutaneous saline injection) (Figure 1A). Body weight
of both treated groups significantly decreased, as com-
pared to controls, and MCT-PE rats had significant
decrease in body weight, as compared to MCT-rats (Fig-
ure 1B). A significant RV hypertrophy developed in
MCT as a consequence of increased pulmonary resis-
tances. The ratio [RVweight]/[(LV+S)weight]i n c r e a s e d
from 0.3 ± 0.03 in C, to 0.81 ± 0.04 in MCT, after 40
days in both groups. All analyzed animals survived until
day 40. Monocrotaline-treated rats with pneumonect-
o m y( M C T / P E )h a dt h eh i g h e s tv a l u e sf o rR V S Pa n d
mPAP. [RVweight]/[(LV+S)weight] ratio was 0.95 ± 0.04 on
day 40 (Figure 1C).
Microscopic morphometry
Lung samples of all animals were evaluated on HE- and
actin-stained slides. Medial wall thickness of pulmonary
arteries (PA)/arterioles between 51-100 μm, as well as
PA between 101-150 μm, 151-250 μm and 251-450 μm
were determined separately. Medial thickness increased
significantly in MCT-animals as compared to the con-
trol group. The most important changes were found in
PA of 51-150 μm size, while PA of 151-450 μmd i s -
played moderate changes (Figure 2A). MCT/PE-animals
consistently presented the highest values for medial
thickness. PA of 151-250 μm, and to a lesser extent of
251-450 μm, showed intense medial remodeling. We
measured adventitial thickness for all groups and corre-
lated them with the external arterial diameter (Figure
2B). We found constant increase of adventitial diameter
in treated groups with significant difference between all.
Lumen areas decreased for MCT and to a higher degree
for MCT/PE, with significant changes for both groups
in PA of all size (Figure 2C). We quantitatively assessed
the degree of muscularization of pulmonary arterioles
with a diameter between 25 and 50 μm, counting 10
arterioles of this size for each slide, at random (Figure
2D). Control-animals showed virtually no muscularized
arterioles of this size. In MCT, the majority of counted
arteries were clearly muscularized, with a circumferen-
tial, actin positive cell layer. In animals of the MCT/PE
group, the percentage of muscularized arterioles was
close to the entire number of counted arterioles. This
pseudo-medial muscularization could not be quantified
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of the tunica media in arteries, that is to say well-
defined internal and external elasticae. Complete occlu-
sion of arterioles was separately assessed (Figure 2E)
and corresponded by trend to the observations made in
Figure 2D. In MCT/PE the vast majority of muscular-
ized arterioles appeared occluded.
Examples of a normal pulmonary artery (control) and
of remodeled pulmonary arteries and arterioles (MCT/
PE) are shown in Figures 2F-H. In addition, arterioles of
the MCT-PE group partially displayed intimal thicken-
ing corresponding to collagen-rich fibrosis, a feature
that was never observed in the MCT group (Figure 2I).
RT-PCR
Expression of DCs, macrophages and mast cells
DC-specific fascin gene expression was increased in
animals of the MCT- and the MCT/PE-group, with
2.4-fold and 3.7 fold higher mRNA-expressions, as
compared to control animals, respectively (Figure 3A).
Increase of macrophage-specific CD68 gene expres-
sion in MCT and MCT/PE animals had a similar
order of magnitude (Figure 3B). Mast cell-specific
tryptase was most dramatically increased in both
models as compared to control rats, with a 110-fold
elevation in MCT/PE, and a 40-fold increase in MCT
(Figure 3C).
Figure 1 Hemodynamics, weight, and right ventricular hypertrophy in experimental PH models and controls. A: diastolic, systolic, and
mean PAP, as well as RVSP (in mmHg) for the different animal-groups. B: body weight (in g), obtained at day 40, shortly before catheterization
and sacrifice. C: right ventricular hypertrophy (ratio) calculated as follows: [RVweight]/[(LV+S)weight]. * P < 0.05 versus control; † P < 0.05 versus
MCT.
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Page 5 of 16Figure 2 Morphometry and histology in experimental PH models and controls. Pulmonary arteries are size-dependently differentiated into
the following categories: 51-100 μm, 101-150 μm, 151-250 μm, and 251-450 μm. A: medial thickness (expressed in % of the cross-sectional
external diameter of arteries). B: adventitial thickness (expressed in per cent of the cross-sectional external diameter of arteries). C: lumen area (in
μm
2). D: arteriolar muscularization (in % of total arteriolar number). E: virtual arteriolar occlusion (loss of visually perceptible lumen, in % of total
arteriolar number). F: normal pulmonary artery (PA) (control) with adjacent bronchiole (HE staining). G: muscularized, virtually occluded arteriole
in a MCT/PE-animal (HE-staining). H: excessive medial thickening in a large PA of an animal from the MCT/PE-group (HE-staining). I: intimal
thickening of a pulmonary arteriole in a MCT/PE animal (HE-staining). * P < 0.05 versus control; † P < 0.05 versus MCT (Figures 2A-E).
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Proinflammatory cytokines were evaluated: IL-6 expres-
sion showed marked elevation with gradual increase
from MCT to MCT/PE. Animals of the latter group had
a 5-fold IL-6 expression increase as compared to C (Fig-
ure 3D). Chemokines fractalkine and RANTES exhibited
significantly increased expression in lungs of hyperten-
sive rats, with significant higher values for fractalkine in
MCT/PE, as compared to MCT (Figure 3E, F).
PAH-associated genes
BMPR1 and BMPR2 were significantly reduced in
hypertensive animals with a 4-fold decrease for BMPR2
in both, MCT- and MCT/PE-animals (Figure 3G).
BMPR1-decrease was more pronounced in MCT/PE as
compared to MCT, although it did not reach statistical
significance (Figure 3H).
Oxidant and anti-oxidant enzymes
Testing of major oxidant enzyme NOX-4 revealed high-
e s te x p r e s s i o ni nM C T / P Ea n i mals (10.3-fold) with sig-
nificant difference to the MCT-group (4.7-fold) (Figure
3I). NOX-2 displayed a significantly higher expression
(3-fold) in the two model groups, with non-significant
decrease in the MCT/PE group (Figure 3J). NOX-1 did
not show any significant differences between the three
groups (Figure 3K), and NOX-3 expression was not
detected at all in either group. Anti-oxidant capacities
revealed mixed results: as compared to the control
group, an increase of anti-oxidants MN-SOD and
gluthation-peroxidase (2.2-fold and 2-fold, respectively)
was observed in MCT/PE (Figure 3L, M). In animals of
the MCT-group only gluthation-peroxidase was signifi-
cantly increased as compared to controls. Anti-oxidant
enzyme HO-1, constituting one of the major defenses
against OS and its products (ROS), revealed 7.3-fold
increase in MCT as compared to controls. However,
animals of the MCT/PE group exhibited 4.8-fold
increase as compared to C, or a 1.5-fold decrease as
compared to MCT (Figure 3N). Contrary to the general
increase in anti-oxidant capacities, anti-oxidant catalase
proved significant decrease in both, MCT and MCT/PE
(1.8-fold and 2-fold, respectively), as compared to con-
trols (Figure 3O).
Immunohistochemical analysis
Detection of vascular dendritic cells
In all lung samples, OX-62
+ dendritic cells were
detected. Control-animals showed discrete but constant
Figure 3 mRNA gene expression measured by real-time PCR.
18s mRNA was used as an internal housekeeping control. Results
are provided as arbitrary units. A: Fascin. B: CD68. C: tryptase. D:
Interleukin-6. E: CX3CL1 (fractalkine). F: CCL5 (RANTES). G: BMPR2. H:
BMPR1A. I: NOX-4. J: NOX-2. K: NOX-1. L: Mn-SOD. M: Glutathione
peroxidase-1. N: Heme oxygenase-1. O: Catalase. * P < 0.05 versus
control; † P < 0.05 versus MCT.
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sue (BALT), but no involvement within pulmonary
arteries (Figure 4A). DCs were also observed in pulmon-
ary septa and pleura of controls. Remodeled pulmonary
arteries of MCT-treated animals presented perivascular
DCs infiltrating the adventitia, but not medial smooth
muscle (Figure 4B). In the MCT/PE group, numerous
cells within the intensely remodeled adventitia revealed
an OX-62
+ phenotype. Here, histiocytes and DCs also
infiltrated the media in a transmural manner (Figure
4C-E). In small pulmonary arteries and arterioles, intra-
luminal wall-adherent leucocytes were observed, includ-
ing DCs (Figure 4C). Immunofluorescence double-label-
ing revealed activated CD68
+/vimentin
+ intramural
macrophages (Figure 4F). Staining with NOX-4- and
Mn-SOD-antibodies revealed a surprisingly high number
of large, cytoplasm-rich cells, containing intracytoplas-
mic granules (Figure 4G-L). The number of NOX-4+
cells was larger than those being MN-SOD+. The cells
were present in the interstitium, in alveolar capillaries
and in the vicinity of remodeled pulmonary vessels and
bronchioles from MCT/PE animals, and MCT animals.
The control group displayed only a few, scattered,
NOX-4+/MN-SOD+ cells (Figure 4I, L). Further immu-
nohistochemical and immunofluorescence experiments
were engaged in order to identify the cell type: CD68,
OX-62, and vimentin did not co-localize with the
described cells (not shown). Immunohistochemical
staining with anti-Tryptase revealed positivity for the
Figure 4 Immunohistochemical/immunofluorescent findings in
lungs from PH models and controls. A: distribution of OX62
+ cells
in lungs of a control; DCs are detected within BALT. B: OX62-
staining in MCT-rats; DCs are infiltrating the adventitia and are
present in BALT. C: PA from a MCT/PE-animal; perivascular OX62+
cells are infiltrating adventitia and media of a remodeled vessel. D:
double-labeling (anti-CD68/anti-actin) in a PA of a MCT/PE-animal:
medial monocytic infiltration. E: double-labeling (anti-OX62/anti-actin
antibodies in a PA (MCT/PE); DCs infiltrate the media. F: double-
labeling (anti-CD68/anti-vimentine) in a PA (MCT/PE); cells within the
media show co-localization of markers (yellow cells). G: anti-NOX-4
staining in a MCT/PE-animal. Interstitial NOX-4+ cells are highlighted.
H: NOX-4+ cells next to a small arteriole (MCT/PE-animal). I: anti-
NOX-4 staining in a control. Few cells display positivity. J: anti-Mn-
SOD staining in a MCT/PE-animal: cells in the range of a remodeled
PA are highlighted. K: A remodeled arteriole displays positivity for
some perivascular cells (MCT/PE-animal). L: Control animal showing
virtual negativity for Mn-SOD+ cells. M: anti-Tryptase staining reveals
positive cells (same cytomorphology and distribution) next to a
small diseased PA (MCT/PE-animal). N: Interstitial tryptase+ cells in
the range of an arteriole (MCT/PE-animal). O: Immunofluorescent
double-staining: merge-photo of a PA in a MCT/PE-animal. NOX-4 =
red, CXCR4 = green and Dapi = blue: note NOX-4+/CXCR4+ cells. P:
Smaller remodeled arteriole displaying cells of the same NOX-4/
CXCR4+ phenotype in the perivascular space. Q: anti-SDF-1 staining
(MCT/PE-animal). Endothelial cells of a diseased PA and a smaller
vessel, inflammatory perivascular cells and bronchial epithelial cells
are positive.
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cular cells, although antibody specificities did not allow
us to perform immunofluorescent double-staining with
NOX-4 (Figure 4M, N). Mast-cell attracting pro-inflam-
matory chemokine SDF-1 and its receptor CXCR4 were
tested by immunohistochemistry and immunofluores-
cence: fluorescent double-staining allowed us to show
intense CXCR4-expression by NOX-4+ mast cells, while
its ligand SDF-1 was expressed by peri-vascular inflam-
matory cells and endothelial cells of pulmonary arteries,
arterioles and veins, as well as by bronchial epithelial
cells (Figure 4O-Q).
Localization of ROS-activity and cytokines
Use of anti-malonedialdehyde antibodies evidenced
intense endothelial staining of pulmonary arteries/arter-
ioles and veins of MCT- and MCT/PE-animals. Positive
staining was also shown for a majority of cells within
the BALT and for infiltrating perivascular leucocytes
(Figure 5A). Anti-nitrotyrosine incubation led to a posi-
tive reaction in endothelial cells of pulmonary vascula-
ture and to a lesser extent in perivascular cells (Figure
5B). Both, nitrotyrosine and to a lesser extent malone-
dialdehyde were present in smooth muscle cells of
affected arteries (Figure 5C). Pulmonary vessels of con-
trol-animals showed exclusively discrete positive staining
of endothelial cells (not shown). Proinflammatory cyto-
kine IL-6 was detected in endothelial cells of pulmonary
arteries, while chemokines RANTES and fractalkine
were localized to perivascular leucocytes (Figure 5D-F).
Discussion
In the present study, we have evaluated the presence of
oxidants and anti-oxidants in experimental pulmonary
hypertension, their enzymatic source, their impact on
pulmonary cellular recruitment and vascular structures.
We used a combined inflammatory-/increased flow-
model of pulmonary hypertension, first described by
Okada and co-workers [21]. The main finding of our
study, is that increased flow in MCT-induced pulmonary
hypertension potentiates three pathological parameters:
production of reactive oxygen species (ROS), remodeling
of pulmonary arteries and hemodynamic deterioration.
These findings provide new evidence for a vicious circle
comprising increased, mast-cell induced OS in the range
of high-flow challenged small pulmonary arteries, hom-
ing of immune-modulating cells to this “Achille’s heel”,
and their contribution to vascular remodeling through
inflammation.
Mast cell steered OS is increased in PH with additional
blood-flow, after pneumonectomy
In our model of combined inflammatory/increased flow-
induced PH, we observed significantly elevated expres-
sion of pro-oxidative enzyme NOX-4 in lungs of rats
from the MCT/PE-group, as compared to controls and
to the MCT-group. Pro-oxidative enzyme NOX-2 was
significantly increased in both, MCT/PE and MCT.
Concomitantly, mRNAs of anti-oxidative enzymes Mn-
SOD and glutathion-peroxidase-1 were significantly ele-
vated in whole lung tissue. Interestingly, we found a 1.5-
fold decrease of anti-oxidant enzyme hemoxygenase-1
(HO-1) in animals with MCT-treatment and increased
blood-flow, versus MCT-treatment only. In addition,
mRNA-levels of catalase, another major anti-oxidative
player were significantly reduced in both, lungs from the
MCT- and from the MCT/PE-group. We tried to loca-
lize the increase of the two main pro- and anti-oxidative
players NOX-4 and Mn-SOD, respectively, within the
diseased lungs. Immunohistochemistry experiments
allowed us to literally highlight a cell population, which
we had not noticed in the first place:diseased lungs of
the MCT/PE, and to a lesser extent of the MCT group
displayed an overwhelming influx of large, cytoplasm-
rich interstitial NOX-4+ and Mn-SOD+ cells, corre-
sponding to tryptase+ mast cells. In addition to the
wide-spread interstitial distribution, NOX-4+ and MN-
SOD+ mast cells were observed in the range of pulmon-
ary arteries and bronchioles. In an attempt to reveal a
possible mechanism for the massive pulmonary homing
of mast cells the recruitment pathway through the SDF-
1/CXCR4 couple was positively tested: SDF-1 was
expressed by endothelial cells of pulmonary vessels and
by perivascular inflammatory cells, while immunofluor-
escent double-labeling revealed CXCR4-expression by
NOX-4+ mast cells. In line with our observation,
CXCR4 is known to be expressed by blood-derived mast
cells and mast cell chemotaxis has been reported to be
mediated by SDF-1 [22,23]. Our group has previously
described the implication of CD117+ cells, comprising
tryptase-positive mast cells and tryptase-negative bone-
marrow derived progenitor cells in human PAH [24],
and increase of pulmonary mast cells has been described
in human PAH [25], as well as in experimental left-heart
independent and left-heart-dependent PH-models
[26,27]. Dahal and co-workers have elegantly shown in
the monocrotaline rat-model, that mast-cell numbers
are significantly increased and that preventive treatment
with the specific c-kit inhibitor PLX and the mast-cell
stabilizer cromolyn sodium salt (CSS) reduce mast-cell
numbers and ameliorate pulmonary vascular remodel-
ing, right-heart hypertrophy and hemodynamics [26].
Interestingly, they were not able to attenuate these three
indicators of PH in a therapeutic (non-preventive) fash-
ion. When considering the vascular and peri-vascular
localization of oxidative stress markers malondialdehyde
and nitrotyrosine (see beneath), one seducing hypothesis
appears to be a ‘bow and arrow’ setting, in which the
mast cells (bow) will have produced enough ROS
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Page 9 of 16Figure 5 Immunohistochemical findings in pulmonary arteries and arterioles from experimental PH models. A: pulmonary arteriole of a
MCT-treated animal; perivascular cells are staining with anti-malonedialdehyd antibody. B: Nitrotyrosin-staining in lungs from a MCT/PE-rat;
endothelial cells within a remodeled pulmonary artery show pronounced staining. C: Pulmonary artery in an MCT-treated animal: in addition to
the endothelial staining, smooth-muscle cells of the tunica media show are, to a lesser extent, nitrotyrosine-positive. D: IL-6 staining reveals
positive endothelial cells in a small pulmonary artery of MCT/PE-treated animals. E: perivascular inflammatory cells express CCL5 (RANTES), F: and
CX3CL1 (fractalkine) in MCT- and MCT/PE-animals.
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arteries) and trigger a self-supporting pro-oxidative and
pro-inflammatory process, which will not be affected by
any mast-cell dependant therapy.
Supporting our findings of increased oxidative imbal-
ance in the MCT/PE model, hemodynamic stress
induced by increased pulmonary blood flow has been
previously proposed as a cause of superoxide anion pro-
duction by oxidant enzymes, such as NOX-4, in cul-
tured human endothelial cells [18]. Of note, increased
ROS production was observed only after cell exposure
to pulsed, unidirectional flow, as compared to non-
pulsed flow. Differentiation between pulsed and non-
pulsed flow in the study of endothelial stress originates
from an earlier work by De Keulenaer and co-workers
[28], where induction of NOX-4 activity is only observed
after exposure of endothelial cell cultures to pulsed
oscillatory shear stress, but not to non-pulsed unidirec-
tional shear-stress. Originally, these data support the
hypothesis of OS generation in plaque-prone regions of
systemic atherosclerotic arteries. It is quite well estab-
lished, that biomechanical forces exerted on the vessel
wall by the flowing blood tend vary at these predilection
sites due to oscillations in blood flow [29]. As a conse-
quence, laminar stress is reduced, whereas volume-
dependent deformation of the vessel wall is enhanced.
In fact, laminar shear stress is believed to protect
arteries from developing intimal lesions, such as athero-
sclerosis, by maintaining endothelial cell nitric oxide
synthesis and by enhancing the activity of anti-oxidant
enzymes, e.g. HO-1. On the other hand, site-dependent
cyclic vessel deformation is known to promote athero-
sclerosis through an increased formation of ROS and
impairment of HO-1 [30,31]. Further more, it has been
recently shown, that stimulation of HO-1 induces an
improvement of endothelial dysfunction in sponta-
neously hypertensive Wistar-Kyoto rats by reducing OS
and increasing NO availability [32]. In a latest study, Yu
and co-workers have shown that ROS overproduction
and NOX-4 increase in a trauma/hemorrhage rat model
can be prevented and trauma-impaired endothelium-
dependent vaso-relaxation restored through stimulation
of HO-1 expression [33]. However, our findings also
demonstrate deterioration of the oxidative balance
through decrease of anti-oxidative enzyme catalase
mRNA in both models as compared to controls, and of
HO-1 mRNA in the MCT/PE group as compared to
MCT alone. This raises the question of a possible
mechanism for the downregulation of such protective
enzyme-encoding genes. A plausible pathway for this
deleterious phenomenon might be triggered by HIF-1
signaling: Loboda and co-workers have recently reported
that induction of HIF-1 in human endothelial cells
through hypoxia and dimethyloxaloylglycine attenuated
the expression of IL-8 and of HO-1 through down-regu-
lation of transcription-factor Nrf2 [34]. The increased
expression and important role of HIF-1 in human PAH
and experimental PH has been addressed by several
authors and is well recognized [35]. It has been reported
that experimental pneumonectomy elicits HIF-1 signal-
ing [36]; hence, a decrease of HO-1 and also of catalase
would be plausible in our model, especially in the MCT/
PE model. Further evidence of a connection between
pulmonary arterial remodeling and oxidative/anti-oxida-
tive balance alterations has been recently provided by
Podlutsky and co-workers [37]. The investigators tested
several major enzymes of the oxidative/anti-oxidative
system in F344-rats of different age (3 to 28 month old)
in order to obtain an age-related profile on the presence
of OS. As aging in the systemic circulation of the elderly
is associated with generalized endothelial dysfunction
and increased OS probably contributing to increased
morbidity and mortality from cardiovascular diseases
[38], the rationale of the study was based on observa-
tions that pulmonary artery pressure and vascular resis-
tance increase with normal aging in humans. The
authors found, that aging in rat pulmonary arteries is
associated with impaired acetylcholine-induced relaxa-
tion and vascular OS. Amongst others, expression of
NOX-4 (mRNA) significantly increased in aged vessels,
whereas expression of catalase significantly decreased. In
contrast, expression of Mn-SOD, and glutathione perox-
idase remained unaltered. Interestingly, this rodent
enzymatic aging-profile of pulmonary arteries is congru-
ent to our findings in permanent high flow-challenged
monocrotaline treated rats, as compared to controls.
The increasing appearance of pulmonary artery adven-
titial fibroblasts (PAFB) in the setting of experimental
hypoxic PH and their contribution to arterial remodel-
ing has been reported in the past [39]. In the context of
human PAH, Li and co-workers have recently studied
the expression of different NOX subunits in PAFB of
human donors under normoxic and hypoxic conditions,
as well as in IPAH-patients [40]. Under hypoxic condi-
tions NOX-4 was significantly upregulated at mRNA
and protein levels. Silencing of NOX-4 by siRNA caused
reduction of ROS levels under both normoxic and
hypoxic conditions and suppressed the significant
hypoxic-induced ROS increase. In addition, PAFB prolif-
eration was significantly decreased in cells transfected
with NOX-4 siRNA, whereas apoptosis was enhanced. A
significant increase of NOX-4 mRNA expression was
observed under hypoxic conditions in PAFB from the
lungs with IPAH compared to healthy donors.
Further more, the role of NOX-4 in human pulmon-
ary artery smooth muscle cells (HPASMC) has been the
subject of a study by Ismail and co-workers [41]. The
investigators show that hypoxia induced HPASMC
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tive oxygen species generation and NOX-4 gene expres-
sion, and is inhibited by antioxidants, the flavoenzyme
inhibitor diphenyleneiodonium (DPI), and NOX-4 gene
silencing.
Our findings suggest that there may be an accentuated
attenuation of the biological anti-oxidant defense system
in MCT/PE-rats as compared to controls, but also as
compared to monocrotaline challenge only. An imbal-
ance between oxidative and anti-oxidative molecules
could contribute to exuberant pulmonary arterial remo-
deling, since histomorphological and hemodynamic dif-
ferences between our two PH-models were marked.
Markers of reactive oxygen species-activity and
inflammation are overexpressed in pulmonary arteries of
hypertensive rats
To test the hypothesis of direct ROS-involvement in
accentuated flow-associated vasculopathy, we studied
the expression of malonedialdehyde and nitrotyrosine in
all groups by immunohistochemical experiments. These
two molecules are established markers of ROS-activity
on lipids, proteins and DNA, respectively [42-44]. We
found increased production of malonedialdehyde and
nitrotyrosine in lung-tissue from MCT- and MCT/PE-
animals, as compared to controls. The main sources of
both markers were endothelial cells, an observation that
has been previously made in lungs from patients with
PAH [20]. In addition but to a lesser extent, medial
smooth-muscle cells stained for both markers. Of inter-
est, malonedialdehyde was markedly produced by peri-
vascular leucocytes of both pulmonary arteries and
veins, suggesting a self-supporting stress circuit through
recruited inflammatory cells. This possibility is sup-
ported by a recent experimental study from De Miguel
and colleagues [45]. The authors report an increased
infiltration of T-lymphocytes into the kidney of rats
with experimental salt-sensitive arterial hypertension
and an increase of NOX-subunits within the attracted
lymphocytes associated with an increase of OS-markers
in the kidney. These pro-oxidative effects were attenu-
ated by preventive immune-suppression through tacroli-
mus, resulting in a decrease of lymphocytic infiltrations
and eventually decrease of arterial hypertension. This
appears of particular interest regarding the close associa-
tion of inflammatory elements and pro-oxidative activity
in our experimental PH-model: as compared to MCT-
animals, hypertensive rats with increased blood flow and
maximal inflammatory infiltrates within the pulmonary
arterial wall exhibited a higher number of remodeled
vessels with production of OS markers. Cytokines IL-6,
RANTES and fractalkine were overexpressed in MCT/
PE and to a lesser extent in MCT, indicating a proin-
flammatory state within lung-tissue. IL-6 expression was
localized to pulmonary arterial endothelium, while the
two latter proteins were mostly expressed by perivascu-
lar leucocytes in our model.
Our previous articles have highlighted an overproduc-
tion of IL-1, IL-6, CCL2 (MCP-1) CXCL1 (fractalkine)
and CCL5 (RANTES) [46]. Recently, Furaya et al [47]
proposed a hypothetical mechanism leading to pulmon-
ary vascular remodeling via overexpression of IL-6. IL-6
induces proliferation and anti-apoptosis in vascular
smooth muscle cells through upregulation of VEGF, and
downregulation of BMPR2 and TGFbR2. Upon IL-6
exposure, endothelial cells undergo apoptosis through
repressed Tie2 signaling via downregulated Ang-1
expression in smooth muscle cells. Production of
CX3CL1 results in recruitmento fi n f l a m m a t o r yc e l l s ,
such as lymphocytes and monocytes, which produce
enormous amounts of IL-6, while vascular smooth mus-
cle and endothelial cells also produce IL-6 upon stimu-
lation with IL-6. This hypothesis is confirmed
experimentally as interleukin-6 overexpression induces
pulmonary hypertension in mice [48]. All the inflamma-
tory mediators we have shown to be overproduced in
PAH are linked to this key cytokine. Indeed, in mouse
serum, mouse CCR2 protein (the receptor for CCL2) is
necessary for expression of mouse IL6 protein that is
increased by experimentally induced sepsis in mouse
[49], and IL1 protein increases expression of CCL2 pro-
tein [50]. IL-1 also increased directly IL-6 mRNA levels
by a protein kinase C-independent mechanism [51] and
IL-1 receptor antagonist treatment reduces pulmonary
hypertension generated in rats by monocrotaline [52].
Moreover, IL-1 may impair the therapeutic effects of
prostacyclin analogues such as iloprost and carbaprosta-
cyclin by attenuating cyclic AMP production by human
pulmonary artery smooth muscle cells in response to
these drugs [53]. At last, in dendritic cells, mouse CCL5
protein increases expression of mouse IL6 mRNA [54].
Further more and in accordance with previous reports
[55], we found decreased expression of PH-associated
genes BMPR2 and of BMPR1A in both, MCT and
MCT/PE, underlining the molecular similarities of those
two animal-models with human familial or idiopathic
PAH when it comes to alterations of BMP/TGF-b
signaling.
Increased blood flow leads to modified arterial wall
proportions in MCT-induced PH
The combination of MCT and pneumonectomy in
young rats as a model for pulmonary hypertension has
been studied for the first time by Tanaka and colleagues
[56]. The authors describe excessive intimal and medial
remodeling of distal pulmonary arteries in those ani-
mals, as compared to MCT alone, which is nearly absent
in animals undergoing pneumonectomy alone. In a
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MCT-penumonectomy model in order to test preventive
and curative effects of dehydroepiandrosterone in
experimental pulmonary hypertension [57]. One week
after MCT injection, left pneumonectomy was per-
formed and sacrifice was done 4.5 weeks later (day 40).
PH was accompanied by severe pulmonary vascular
remodeling, consisting of small pulmonary arterial med-
ial wall thickening, increased adventitial cellularity and
to a lesser extent arteriolar neointimal lesions.
Indeed, microscopic morphometrical evaluation
revealed significant differences between our two pul-
monary hypertensive groups. First, excessive musculari-
zation of arterioles of less than 50 μmi ne x t e r n a l
diameter was observed in both, MCT- and MCT/PE-
animals. However, this phenomenon was quantitatively
more pronounced in the latter group. In addition to
arteriolar muscularization, the MCT/PE group displayed
discrete intimal thickening with increased cellularity in
small arterioles, as it has been described by Tanaka and
by Homma. This observation might be of importance in
the context of an experimental PH-model, since most
PH-models generate medial thickening and adventitial
remodeling, but lack intimal lesions, a hallmark of
human PH.
Our results are Further more consistent with recent
data showing the consequences of right-sided lobec-
tomies in a rat model indicating that arteriolar muscu-
larization occurs in rats with triple-lobectomy (quasi
equal to pneumonectomy), but not in double-lobectomy
[58]. The authors describe a muscular thickening of pul-
monary arterioles in between an external diameter of 30
to 80 μm, while remodeling of pulmonary arteries of
over 100 μm is not reported. Interestingly, our study
reveals qualitative differences of arterial remodeling
between the MCT- and the MCT/PE-group, concerning
pulmonary arteries with an external diameter ranging
from 101 to 450 μm. Medial and adventitial thickening
in MCT/PE-animals exceeded values in MCT-treated
rats significantly. In fact, exuberant adventitial cellularity
was observed to a smaller extent in MCT, while consis-
tently present in MCT-PE. In accordance with excessive
wall dimensions, MCT/PE exhibited significantly lower
surface areas of arterial lumina than MCT, underlining
the obstructive character of vascular remodeling.
Dendritic cells and CD68
+ cells are massively recruited to
remodeled arteries of hypertensive rats with increased
blood-flow
We have previously demonstrated that DCs may be
involved in hypertensive pulmonary vasculopathy, since
they are recruited to arterial lesions in experimental
and human PH. DCs are mainly known as antigen pre-
senting cells connecting the innate immunity to the
adaptive immune response when facing danger signals
and inducing tolerance to self-antigens in a non alerted
immunitary state [59]. Under inflammatory conditions,
DCs orchestrate the immune response through activa-
tion and initialization of T-lymphocytes, but may also
communicate with B-cells and fibroblasts [60]. In pre-
vious reports, DCs have been demonstrated to organize
arterial inflammatory lesions in systemic atherosclero-
sis [61]. Noteworthy, a recent study has demonstrated
an increased DC resistance towards organic and hydro-
gen peroxides through overproduction of manganese
superoxide dismutase [62]. In systemic arteries DCs
accumulate in regions displaying hemodynamic stress
by turbulent flow conditions and being prone to hyper-
tensive intimal lesions [17]. We observed intense
recruitment of DCs into the wall of affected pulmonary
arteries in MCT/PE-rats and to a lesser extent in
MCT-rats. DCs were uniformly present within the
dense adventitial cell-accumulations in MCT/PE and
frequently infiltrated medial smooth-muscle-cells, up
to subintimal regions. Noteworthy, in all groups,
including control animals, numerous DCs were
detected within BALT, while interstitial DCs were
sparse. This finding is supported by previous observa-
tions mainly locating myeloid dendritic cells within the
range of isolated pulmonary lymphoid follicles and
BALT in the context of pulmonary interstitial diseases,
in particular rheumatoid arthritis (RA) and Sjögren’s
syndrome (SS) [63,64].
In MCT/PE-animals, adventitial thickening mainly
consisted in cells staining for CD68. However, in arteries
presenting intense adventitial cellularity, we detected a
pronounced medial infiltration by CD68
+/vimentin
+
cells. These cells, to some extent, morphologically dis-
played a fusiform pattern and were uniformly arranged
within the muscular compartment, explaining difficult
differentiation on HE-stained slides. Frid and co-workers
have reported the arterial recruitment of mesenchymal
precursors of a monocyte/macrophage lineage, including
circulating fibrocytes, in hypoxic lungs of calves and rats
[65]. Recently, Burke and colleagues have reported
influx of immune cells, including dendritic cells, into
the pulmonary arterial walls of Wistar-Kyoto rats during
sustained hypoxia, and concomitant increase of pro-
inflammatory cytokines, growth factors and adhesion
molecules [66]. More specifically, the investigators
observed an increase in the appearance of OX62+ den-
dritic cells in the peri-adventitial region of vessels from
chronically hypoxic animals on days 7 and 28. Interest-
ingly, it has also been shown that activated macrophages
express vimentin only in proinflammatory conditions
under the influence of proinflammatory cytokines and
that macrophagic vimentin secretion is an important
source of oxidative metabolite generation [67]. These
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inflammatory action/reaction and OS.
Conclusion
We report increased OS activity in hypertensive lung
vasculature of MCT-treated, high-flow challenged rats
associated with an imbalance of pro- and anti-oxidative
enzymes and massive ROS-generating mast-cell-influx.
MCT/PE-animals display severe intimal, medial and
adventitial, functionally relevant remodeling with pro-
inflammatory cytokine-dependant massive infiltration of
CD68
+/vimentin
+ cells and immune-modulating dendri-
tic cells into the pulmonary arterial wall. Our data indi-
cate that, in experimental PH, mast cell-steered increase
of OS and peri-vascular inflammatory cell-signaling are
related and partly induced by increased blood-flow and
could favor pulmonary arterial remodeling.
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